Low-profile prosthetic valve structure

Information

  • Patent Grant
  • 9931205
  • Patent Number
    9,931,205
  • Date Filed
    Friday, October 7, 2016
    7 years ago
  • Date Issued
    Tuesday, April 3, 2018
    6 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Yabut; Diane
    • Herbermann; Erich
    Agents
    • Inskeep IP Group, Inc.
Abstract
A prosthetic valve assembly that includes a stent, a tissue sleeve and an anchoring mechanism. By loading the three components of the valve assembly into a delivery catheter in a series formation, such that no two components are located within each other, the size of the delivery catheter can be reduced.
Description
BACKGROUND OF THE INVENTION

Replacing heart valves with prosthetic valves was, until recently, a complicated surgical procedure that involved cutting open the chest, establishing blood flow through a blood pump, stopping the heart, etc. This complicated procedure, even when performed perfectly, required extensive recovery time due to the invasiveness and damage done to access the implantation site. Additionally, the risk of infection or other complications is extremely high.


Numerous advancements have been made to develop prosthetic valves that can be implanted percutaneously, using a catheter to snake the prosthetic valve through the vasculature to the implantation site. If successful, the recovery time is greatly minimized relative to conventional open-heart surgery.


A designer of a percutaneously-delivered prosthetic valve is faced with numerous challenges, however. First and foremost is designing a prosthetic valve that can be compressed enough to be inserted into a catheter small enough to be navigated to the valve site through the vasculature. Other challenges include anchoring the valve at the valve site so the valve does not migrate after release; including a support structure for the valve that is robust enough to push the native, often calcified valve out of the way and prevent it from later interfering with the function of the new valve; ensuring that the new valve allows proper flow in a desired direction and effectively stops flow in the opposite direction; ensuring that no blood flows around the sides of the implanted device (this is known as perivalvular leakage); designing a prosthetic valve device that does not fail due to fatigue after hundreds of thousands of cycles of leaflet function; designing a valve that meets all of these criteria and can still be manufactured economically; and the list goes on.


These prosthetic valves, and their respective delivery catheters, are designed to replace a particular native valve, such as the aortic valve, for example. Percutaneous navigation to a valve is easiest, and least traumatic to the patient, when a smaller catheter is used. Smaller catheters, however, present challenges when designing effective prosthetic valves that can be compressed enough to fit, and slide, within the lumen of a small catheter, such as a 16 Fr or even a 14 Fr catheter. Significant strides have been made in recent years in designing prosthetic valves that have reduced profiles when in a catheter-loaded configuration. For example, the devices described in U.S. Patent Publication Number 2006/0271166 to Thill et al., the contents of which are incorporated by reference herein, can assume an elongated, unfolded configuration when loaded into a catheter and, when released from the catheter at a target site, resume a folded configuration. The present invention is directed to taking this innovative concept and presenting additional ways that the loaded configuration could present an even lower profile.


OBJECTS AND SUMMARY OF THE INVENTION

One aspect of the invention is directed to a prosthetic valve device that presents a low profile in a catheter-loaded configuration.


Another aspect of the invention is directed to a prosthetic valve device that is sized to replace an aortic valve and capable of being delivered using a small, flexible catheter.


Another aspect of the invention is directed to a prosthetic valve device that comprises two components are connected but positioned in series (spaced apart axially) in a delivery catheter to reduce the size of the delivery catheter required.


One aspect of the invention provides a device for replacing a native valve comprising: a stent; a tissue sleeve; and, an anchoring mechanism usable to secure said tissue sleeve within said stent; wherein, in a configuration inside a delivery catheter, said anchoring mechanism is not located within said stent; and wherein, in a deployed configuration, said tissue sleeve is located within said stent.


Another aspect of the invention provides prosthetic valve device that comprises a braided anchoring mechanism connected at a proximal end to a wireform.


Another aspect of the invention provides an implantable device that includes a support structure having an extended configuration and a folded configuration, the support structure having a first end, a second end and a preformed fold between said first end and said second end, wherein said preformed fold at least assists in inverting said first portion into said second portion when said support structure is released from a delivery device, and a prosthetic valve structure including a hinged end hingedly attached to said support structure first end, thereby allowing said support structure first portion to invert into said support structure second portion without inverting said prosthetic valve structure.


Another aspect of the invention provides an implantable prosthetic valve structure with a support structure that has a folded configuration in which the prosthetic valve structure extends, at least partially, into said support structure.


Another aspect of the invention provide a prosthetic valve device that includes a support structure that has inwardly curved sidewalls when it is in a folded configuration.





BRIEF DESCRIPTION OF THE DRAWINGS

These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which



FIG. 1 is an elevation of an embodiment of the invention;



FIG. 2 is an elevation of an embodiment of the invention in a folded configuration;



FIG. 3 is a partial view of an embodiment of the invention;



FIG. 4 is a partial view of an embodiment of the invention; and



FIG. 5 is a partial view of an embodiment of the invention.





DESCRIPTION OF EMBODIMENTS

Specific embodiments of the invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements.


Referring first to FIG. 1 there is shown a device 10 of the invention. Device 10 generally includes a support structure 20, a valve assembly 40, and a connection 60 between the support structure 20 and the valve assembly 40. FIG. 1 shows the device 10 in an elongate configuration prior to being compressed in order to fit within the lumen of a delivery catheter. It can be seen that the support structure 20, the valve assembly 40, and the connection mechanism 60 are all linearly arranged along a longitudinal axis in a series configuration, with no overlapping of components.


With regard to the support structure, a dotted line 22 represents a preformed fold created in the support structure 20 that at least partially causes the device 10 to fold inwardly on itself when released from a delivery catheter. The support structure 20 can be described as having a first end 24, a first portion 26 between the first end 24 and the preformed fold 22, a second end 30, and second portion 32 between the second end 30 and the preformed fold 22.


The valve assembly 40 includes tissue valve 42 attached to a wireform 40. The wireform 40 gives structural integrity to the tissue valve 44.


The connection 60 between the valve assembly 40 and the support structure 20 is described in more detail below.



FIG. 2 shows the device 10 of FIG. 1 in a fully expanded, delivered configuration. The device 10 has folded inwardly on itself such that the fold 22 is now defining the proximal end of the support structure 20. As the device 10 folded, the wireform 40, which contains a tissue valve 42, is drawn into the support structure 20. Because the first portion 26 is now inverted, in other words, it is inside-out in comparison to its prefolded configuration of FIG. 1, the connection mechanism 60 must hinge or pivot in order to maintain the orientation of the valve assembly 40. Because the connection mechanism 60 hinges, when the first portion 24 inverts into the second portion 32, the valve assembly 40 moves only linearly (axially) into the support structure 20, as shown by the arrow 100 in FIG. 2. Thus, only one preformed fold 22 is needed in the support structure 20 to allow the valve assembly 40 to maintain its orientation while moving axially.



FIG. 3 shows an embodiment of a connection mechanism 60. The connection mechanism 60 may be a link 62 having two ring connectors 64 separated by a spacer 66. The spacer 66 is sized to ensure that, in the elongated configuration, the connection mechanism 60 adequately separates the support structure 20 from the valve assembly 40. The connection mechanism 60 may be constructed of a variety of bio-compatible material such as an alloy, including but not limited to stainless steel and Nitinol, or may be a polymer or other suitable non-metallic material.



FIG. 4 shows another embodiment of a connection mechanism 60. This connection mechanism 60 may be a tether 70 having ends 72 that are tied to the wireform 44 of the valve assembly 40 and to the support structure 20. The tether may be constructed of any suture material or may be a wire having suitable flexibility to be tied in a knot. The length of the tether 70 between the tied ends 72 constitutes a spacer 74 that is sized to ensure adequate separation of the support structure 20 from the valve assembly 40 in the elongated configuration of FIG. 1.



FIG. 5 shows an embodiment of a connection mechanism 60 that is a single loop 80. The loop 80 extends around the wireform 44 and a strand of the support structure 20. The loop 80 is sized to ensure adequate separation of the support structure 20 from the valve assembly 40 in the elongated configuration of FIG. 1.


Although the invention has been described in terms of particular embodiments and applications, one of ordinary skill in the art, in light of this teaching, can generate additional embodiments and modifications without departing from the spirit of or exceeding the scope of the claimed invention. Accordingly, it is to be understood that the drawings and descriptions herein are proffered by way of example to facilitate comprehension of the invention and should not be construed to limit the scope thereof.

Claims
  • 1. An implantable device comprising: a support structure having a single preformed fold and an unfolded configuration and a folded configuration and including: a first end;a second end directed away from said first end; and,a lumen extending between said first end and said second end;wherein said support structure is biased toward a folded configuration in which said first end is inverted into said lumen, such that the first end and the second end are both oriented in a common direction;wherein said support structure tends to assume said folded configuration when said support structure is released from a delivery device;a prosthetic valve structure hingedly attached to said support structure first end such that said prosthetic valve structure is not inverted when said support structure inverts.
  • 2. The implantable device of claim 1 wherein said hinged end is attached to said support structure first end with a connector.
  • 3. The implantable device of claim 2 wherein said connector comprises a hinge.
  • 4. The implantable device of claim 2 wherein said connector comprises a link.
  • 5. The implantable device of claim 4 wherein said link comprises two ring connectors separated by a spacer.
  • 6. The implantable device of claim 1 wherein, in said unfolded configuration, said connector separates said support structure from said valve assembly.
  • 7. The implantable device of claim 1 wherein said connector comprises a tether.
  • 8. An implantable device comprising: a support structure having a first end and a second end and a lumen therebetween, and a single preformed fold;a valve assembly;a connector connecting said valve assembly to said first end of said support structure;wherein said implantable device has a first configuration and a second configuration;wherein in said first configuration, said support structure is unfolded, said first end faces a first direction and said second end faces a second direction opposite said first direction, and said support structure, said valve assembly, and said connector are axially arranged;wherein in said second configuration, said single preformed fold is folded and said first end is inverted into said lumen such that said first end faces said second direction and said valve assembly is drawn at least partially into said lumen by said connector.
  • 9. The implantable device of claim 8 wherein said connector pivots such that said when said support structure inverts, said valve assembly does not invert.
  • 10. The implantable device of claim 8 wherein said connector comprises a hinge.
  • 11. The implantable device of claim 8 wherein said connector comprises a link.
  • 12. The implantable device of claim 11 wherein said link comprises two ring connectors separated by a spacer.
  • 13. The implantable device of claim 8 wherein, in said first configuration, said connector separates said support structure from said valve assembly.
  • 14. The implantable device of claim 8 wherein said connector comprises a tether.
  • 15. The implantable device of claim 14 wherein said tether comprises a first end tied to the support structure and a second end tied to the valve assembly.
  • 16. The implantable device of claim 8 wherein said connector comprises a loop.
  • 17. A method of delivering an implantable device comprising: arranging a first component, a connector, and a second component axially in a delivery catheter, said first component in an unfolded configuration but having a single preformed fold that is biased toward a folded configuration; said connector connecting said first component and said second component such that said first and second components do not overlap;releasing said first component, said connector, and said second component at a target site from said catheter;allowing said first component to assume said folded configuration such that opposite ends thereof face a common direction while said connector pivots, thereby drawing said second component axially toward said first component.
  • 18. The method of claim 17 wherein releasing said first component, said connector, and said second component at a target site from said catheter comprises first releasing said first component followed by releasing said connector and said second component.
  • 19. The method of claim 17 wherein arranging a first component, a connector and a second component axially in a delivery catheter comprises arranging a support structure, a connector, and a valve assembly in a delivery catheter.
  • 20. The method of claim 17 wherein arranging a first component, a connector, and a second component axially in a delivery catheter, said first component in an unfolded configuration but biased toward a folded configuration; said connector connecting said first component and said second component such that said first and second components do not overlap, comprises arranging said first component, said connector, and said second component axially in said delivery catheter such that said first component and said second component are spaced apart from each other.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/212,442, filed Mar. 14, 2014, now U.S. Pat. No. 9,486,314, entitled Low-Profile Prosthetic Valve Structure which is related to and claims priority benefit of U.S. Provisional Application Ser. No. 61/800,153 filed Mar. 15, 2013 entitled Low-Profile Prosthetic Valve Structure, all of which are hereby incorporated by reference herein in their entireties.

US Referenced Citations (75)
Number Name Date Kind
4056854 Boretos et al. Nov 1977 A
5549665 Vesely et al. Aug 1996 A
5669931 Kupiecki et al. Sep 1997 A
5843260 Huskey Dec 1998 A
5846261 Kotula et al. Dec 1998 A
6015431 Thornton et al. Jan 2000 A
6016810 Ravenscroft Jan 2000 A
6126686 Badylak et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6287335 Drasler et al. Sep 2001 B1
6378028 Inagawa et al. Apr 2002 B2
6402780 Williamson, IV et al. Jun 2002 B2
6425916 Garrison et al. Jul 2002 B1
6478028 Paolitto et al. Nov 2002 B1
6524339 Adams Feb 2003 B1
6592614 Lenker et al. Jul 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6652578 Bailey et al. Nov 2003 B2
6719781 Kim Apr 2004 B1
6769434 Liddicoat et al. Aug 2004 B2
6893457 Dong May 2005 B2
6908481 Cribier Jun 2005 B2
6929653 Strecter Aug 2005 B2
7001425 McCullagh et al. Feb 2006 B2
7252681 Berg et al. Aug 2007 B2
7267686 Dimatteo et al. Sep 2007 B2
7329279 Haug et al. Feb 2008 B2
7445630 Lashinski et al. Nov 2008 B2
3021420 Dolan Sep 2011 A1
8157796 Collins et al. Apr 2012 B2
8663312 Wilson et al. Mar 2014 B2
8696737 Gainor Apr 2014 B2
8845720 Conklin Sep 2014 B2
8986374 Cao et al. Mar 2015 B2
20020032481 Gabbay Mar 2002 A1
20020128703 Ravenscroft Sep 2002 A1
20030014104 Cribier Jan 2003 A1
20040024416 Yodfat et al. Feb 2004 A1
20040073293 Thompson Apr 2004 A1
20040073301 Donlon et al. Apr 2004 A1
20040093075 Kuehne May 2004 A1
20040220664 Chobotov Nov 2004 A1
20040260333 Dubrul et al. Dec 2004 A1
20050022674 Campbell et al. Feb 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050222674 Paine Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050251251 Cribier Nov 2005 A1
20050283231 Haug et al. Dec 2005 A1
20060020327 Lashinski et al. Jan 2006 A1
20060074484 Huber Apr 2006 A1
20060142848 Gabbay Jun 2006 A1
20060167468 Gabbay Jul 2006 A1
20070010876 Salahieh et al. Jan 2007 A1
20070203517 Williams et al. Aug 2007 A1
20080015671 Bonhoeffer Jan 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080195199 Kheradvar et al. Aug 2008 A1
20080300678 Eidenschink et al. Dec 2008 A1
20090076598 Salahieh et al. Mar 2009 A1
20090222076 Figulla et al. Sep 2009 A1
20100161028 Chuter Jun 2010 A1
20100168839 Braido et al. Jul 2010 A1
20110218619 Benichou et al. Sep 2011 A1
20110264206 Tabor Nov 2011 A1
20110282439 Thill et al. Nov 2011 A1
20120065728 Gainor et al. Mar 2012 A1
20120209370 Thill et al. Aug 2012 A1
20130144383 Thill et al. Jun 2013 A1
20130204357 Thill et al. Aug 2013 A1
20130204360 Gainor Aug 2013 A1
20130282098 Thill et al. Oct 2013 A1
20140155996 Wilson et al. Jun 2014 A1
Foreign Referenced Citations (46)
Number Date Country
2863503 Aug 2013 CA
101991478 Apr 2013 CN
102005052628 May 2007 DE
1 915 105 Apr 2008 EP
2 809 272 Dec 2014 EP
2 967 861 Jan 2016 EP
H0611637 Jan 1994 JP
H1029161 Feb 1998 JP
2000-291883 Oct 2000 JP
2002-182095 Jun 2002 JP
2002-228903 Aug 2002 JP
2002-328317 Nov 2002 JP
2002-537943 Nov 2002 JP
2003-506133 Feb 2003 JP
2003-098443 Apr 2003 JP
2004-503327 Feb 2004 JP
2007-237136 Sep 2007 JP
4093401 Jun 2008 JP
4549278 Sep 2010 JP
5289049 Sep 2013 JP
2014-000472 Jan 2014 JP
2015-509033 Mar 2015 JP
5749231 Jul 2015 JP
2016-028783 Mar 2016 JP
2016-064147 Apr 2016 JP
1997027799 Aug 1997 WO
1997030659 Aug 1997 WO
1999015112 Apr 1999 WO
2000053120 Sep 2000 WO
2002005729 Jan 2002 WO
2003092554 Nov 2003 WO
2004082528 Sep 2004 WO
2006036690 Apr 2006 WO
2005058408 Jun 2006 WO
2006083763 Aug 2006 WO
2006128193 Nov 2006 WO
2007051620 May 2007 WO
2008072838 Jun 2008 WO
2008097589 Aug 2008 WO
2009153768 Dec 2009 WO
2011143263 Nov 2011 WO
WO 2012173995 Dec 2012 WO
WO 2013078497 Jun 2013 WO
2013116785 Aug 2013 WO
WO 2014110019 Jul 2014 WO
2014144020 Sep 2014 WO
Related Publications (1)
Number Date Country
20170020667 A1 Jan 2017 US
Provisional Applications (1)
Number Date Country
61800153 Mar 2013 US
Continuations (1)
Number Date Country
Parent 14212442 Mar 2014 US
Child 15288543 US